China National Biotec Group was awarded approval to conduct Phase III trials for its Covid-19 vaccines in the Middle Eastern country.The company will partner with Abu Dhabi-based artificial intelligence and cloud computing firm G42 to carry out the trial and local production of the vaccine
from Livemint - News https://ift.tt/37V0L64
https://ift.tt/eA8V8J
from Livemint - News https://ift.tt/37V0L64
https://ift.tt/eA8V8J
إرسال تعليق